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Introduction: Solid pseudopapillary tumor (SPT) of the pancreas is rare, accounting for 0.13-2.7% 
of all pancreatic tumors. It has specific clinical, pathological and radiological characters that make it 
quite different from other pancreatic tumors. 
Presentation of case:  A 15-year-old girl with SPT of the pancreas diagnosed after surgical 
resection with histopathology and immunohistochemistry confirmation. As no clear role for adjuvant 
treatment, she was elected for follow up. 
Conclusion: Although SPT is a rare tumor without notable symptoms. Complete surgical excision is 
the treatment of choice. The place of chemotherapy or radiotherapy needed to be elucidated.  
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Introduction 
Solid pseudopapillary tumor of the pancreas (SPT) is an uncommon pancreatic neoplasm. This study 
reports a case of SPT of the pancreas, and our experience in diagnosis and management over three years. 
Case Report 
A 15-year-old girl with no prior medical or surgical history referred to our oncology center as a case of 
recurrent hemorrhagic pancreatic cyst for further management. The condition started 5 months back when 
she started to complain from epigastric pain, nausea and vomiting with decreased appetite. On physical 
examination, her abdomen was not distended but tender on palpation in epigastric region. There were no 
palpable masses, and bowel sounds were audible. On laboratory testing, she had a serum chemistry panel 
and complete blood count within normal limits except CA 19.9 was 93.68 U/ml.  A computed 
tomography scan revealed well – defined cystic lesion of 5 cm diameter with thick soft tissue wall of 























 Figure 1 CT abdomen before surgical interference 
Ultrasound-guided fine-needle aspiration (FNA) biopsy yielded pictures of simple hemorrhagic cyst. The patient 
underwent a distal pancreatectomy with spleenectomy where an 8 x 4 x 1.5 cm well-circumscribed mass was 
removed from pancreatic body and tail. Histological examination revealed loosely cohesive round cells with 
uniform nuclei, clear cytoplasm with rare mitosis (Fig 2); 
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Figure 2 pseudo papillary tumor (63XH&E) 
 
 tumor size: 3 x 2 cm, presences of lymphovascular and perineural invasion, margins were uninvolved by 
tumor with distant from closet margin was 0.1 cm and one lymph node was negative for metastasis (0/1). 
Immunohistochemical staining showed neoplastic cells to be positive for vimentin, CD10, CD 56, and 
























Figure 3b (IHC 40x) positive for beta-catenin (left) and positive forCD10 (right) while negative for chromogranin. 
Focal weak positivity is noted for neuron specific enulase (NSE) 
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The patient had a smooth recovery and was discharged 10 days after operation. Re-evaluation post 
operation by CT scan revealed no evidence of tumor residual. Also there was decrease in serum CA19.9 
U/ mL with serial measurements, with last one near the normal ranges. From that time, she is under 
follow up without evidence of local or systemic recurrence. 
Discussion 
During the period from June 2011 to November 2013; 36 patients were diagnosed as primary pancreatic 
tumors in King Abdullah Medical City Oncology Center; our case is the first and only one diagnosed as 
solid pseudo papillary which represents 2.7% of all pancreatic tumors; this is corresponding to 
international percentages [1]. SPT is firstly described by Frantz in 1959[2]. 
Different names of this tumor were reported and according to its macroscopic and microscopic 
pathological characteristics over the years. It has been given multiple descriptive names such as 
papillary-cystic tumor, solid cystic tumor, papillary epithelial neoplasm, solid, and papillary neoplasm, 
papillary tumor of the pancreas, or Frantz’s tumor until it was defined by the World Health Organization 
(WHO) in 1996 as a “solid pseudo papillary tumor” of the pancreas [3]. 
In a large retrospective review included 718 patients with SPT, more than 90 % of the patients were 
young women with 10:1 predominance over men and usually in the second or third decade of life [4]. 
Clinical features are usually vague and nonspecific including abdominal pain, dyspepsia, early satiety, 
and vomiting due to bulky tumor compressing the upper abdomen.  Up to 20% of patients discovered 
accidentally either on imaging or at operation for unrelated pathology [5, 6]. 
The pathogenesis still remains unknown, although its tendency to affect young women has suggested 
that sex hormones may contribute in the origin of SPT. In the immunohistochemical staining for sex 
hormone-receptor proteins and clinicopathological characteristics, no difference has been attributable to 
gender alone [7]. Sun et al reported that 62.5% of SPT patients are infected with hepatitis B virus (HBV), 
which can induce over-expression of β-catenin in tumor cells, indicating that HBV infection may be 
involved in the pathogenesis of SPT, which, however, has not been confirmed by other researchers [8]. 
Radiological findings include the presence of an encapsulated mass with two components solid and cystic 
on either CT scan or MRI, with MRI notably better for identification of special tumor characteristics such 
as the presence of a capsule, hemorrhage, necrosis or cystic degeneration [9]. Pathologically, SPTs are 
identified as well demarcated from adjacent pancreatic tissues by fibrous capsule. Microscopic 
examination yields mixed solid and cystic components with regions of necrosis and hemorrhage. 
Characteristic findings include the presence of solid areas alternating with pseudopapillary formations, 
foamy histiocytes, nuclear grooves and cytoplasmic globules [10]. 
As the origin of this tumor remains unclear, the immunohistochemistry is needed for accurate diagnosis. 
SPT is typically positive for vimentin (Vim), a-1-antitrypsin (AAT), a-1- antichymotrypsin (AACT), and 
neuron specific enolase (NSE) [11]. However, the unique immunohistochemical features with expression 
of CD56 and CD10 have not reached an agreement in a recent study, also SPT cells may reveal focal 
immunoreactivity for cytokeratin (CK) and synaptophysin (Syn), abnormal nuclear location of β-catenin, 
and presence of progesterone receptors (PR), and may express galectin-3, all of which are useful in 
differentiating SPT from endocrine pancreatic tumor [12]. 
Furthermore, SPT rarely develops outside the pancreas and up to 95% are localized to it at the time of 
diagnosis [13]. Extra pancreatic SPT cases have been reported in retroperitoneum, liver, omentum, and 
mesocolon. Some of them were considered to arise from an ectopic pancreas [14]. 
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Although they have low malignant potential, they can invade locally and when distant metastasis present, 
usually considered as synchronous disease to the liver and/or peritoneum. Any patient with a solid and 
partly cystic mass of the pancreas especially in females under 35 years of age SPT should be added to the 
differential diagnosis which should include microcystic adenoma, mucinous cystic neoplasm, 
nonfunctioning islet cell tumor, pancreatic adenocarcinoma, pancreaticoblastoma, cystic degeneration of 
solid neoplasm and calcified hemorrhagic pseudocyst [15]. 
The prognosis of SPTs is good, even with local recurrence, as well as metastases or invasions. More 
than 95% of patients with SPTs limited to the pancreas are cured by complete surgical excision. The 
overall 5-year survival was estimated to be 95% in a review of 718 patients reported in the English 
literature. The role of adjuvant therapy in treatment of SPT is unclear, with few studies demonstrated a 
role for gemcitabine and radiotherapy to downsize large tumors or treat the rare unrespectable cases [16]. 
Local recurrence is reported to be less than 10%, and usually within 4 years of surgery. Recurrence, local 
invasion, and limited metastases are not contraindications for resection, and long-term survival has also 
been observed in patients with SPTs [17].  
Owing to the favorable prognosis and excellent long term survival, even in the presence of local 
recurrence or stable metastases, predictive factors of survival are difficult to identify. However in some 
review articles considered the presence of vascular invasion, tumor size greater than five cm and low 
nuclear grade as poor prognostic factors [18]. On other study done by Washington et al showed that the 
clinical and pathologic features of SPT, including diffuse growth, venous invasion, nuclear pleomorphism, 
mitotic rate, necrosis and dedifferentiation, are related to its aggressive behavior or metastatic potential 
[19]. 
Kemi and Grant evaluated the chromosomal changes in SPT and considered DNA aneuploidy, double 
loss of X chromosomes, trisomy for chromosome 3, unbalanced translocation between chromosomes 13 
and 17 are associated with its aggressive behavior and may be indicators of its possible metastatic 
potential [20]. 
In our case, the diagnosis was based on radiological, pathological and immunhistochemical finding. 
Although that the patient had many apparently bad prognostic features as the presence of lymphovascular 
and perineural invasion with close surgical margin, but in lack of sufficient evidence from literature and 
good prognosis even in the presence of local recurrence or metastasis, the case was elected for only 
follow up and now continued for 13 months without evidence of local or systemic recurrence. 
Conclusion 
SPT is a rare pancreatic tumor with non specific presentation. The accuracy of diagnosis may be 
improved by immunohistochemical staining as such tumors are typically negative for cytokeratin and 
pancreatic enzyme markers, but positive for vimentin, CD 10, CD 56.Whenever possible, surgical 
resection is the treatment of choice with excellent long-term survival. Further studies needed for 
establishing guidelines for SPT treatment and clarify the role of chemotherapy or radiotherapy. 
Ethical consideration 
Ethical approval to conduct the study was sought from the IRB review committee before the 
commencement of the study. 
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